FDA Inspection 1070144 — Reliance Life Sciences Private Limited

Reliance Life Sciences Private Limited — FEI 3009510975

The FDA completed an inspection of Reliance Life Sciences Private Limited on October 16, 2018 in Navi Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 16, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Navi Mumbai (India)